Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rongjin Juanbi
- Development stage
- Unknown
- Lead developer
- Beijing Handian Pharmaceutical
- Administration
- Oral
01
Overview
Rongjin Juanbi is a proprietary Traditional Chinese Medicine (TCM) granule formulation primarily indicated for the treatment of musculoskeletal disorders characterized by pain, stiffness, and numbness, collectively known as "Bi syndrome" in TCM. Developed and manufactured by companies such as Beijing Handian Pharmaceutical, the formulation is composed of a complex mixture of herbal extracts, including *Radix Angelicae Sinensis*, *Radix Paeoniae Alba*, and *Radix Gentianae Macrophyllae*. It is designed to nourish the liver and kidneys, replenish blood, relax tendons, and dispel wind and dampness. Clinically, it is used to manage conditions such as rheumatoid arthritis, osteoarthritis, cervical spondylosis, and lumbar disc herniation. The therapeutic effects are attributed to the synergistic action of its herbal constituents, which exhibit anti-inflammatory and analgesic properties by modulating pro-inflammatory cytokines and improving local microcirculation.
- Brand names
- Rongjin Juanbi
- Other names
- Rongjin Juanbi Keli荣筋蠲痹颗粒
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))PTGS2 (Prostaglandin-Endoperoxide Synthase 2)IL1B (Interleukin-1 beta)
Beyond the preview
Go deeper on Rongjin Juanbi.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rongjin Juanbi.